In Brief: Chiron/J&J Home HIV test
This article was originally published in The Gray Sheet
Chiron/J&J Home HIV test: Chiron predicts approval "by the middle of this year" for Johnson & Johnson's Confide home HIV test kit. "J&J plans to do a test launch in about four cities this year and then roll it out nationally in all markets in 1996," Chiron's VP-corporate communication Larry Kurtz tells May 17 Alex. Brown & Sons healthcare seminar in Baltimore. Kurtz notes that "this will indeed be a very good market," and that profits are expected "in the next several years." Chiron and J&J's Direct Access Diagnostics entered an agreement last fall by which Chiron has an option to pay J&J $12 mil. during 1994 and 1995 to become an equity partner in the Confide effort. The two firms will split pre-tax profits generated by the product...
You may also be interested in...
The director of adult immunizations at Johns Hopkins International Vaccine Access Center talks to Scrip about undertaking a massive COVID-19 vaccination effort in the US.
P&G’s oral care business drove 35% of total category market growth in the firm’s fiscal 2020 and exemplifies its growth strategy for all segments – grow entire categories rather than take competitors’ market share, says CFO Jon Moeller.
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.